Announcement
29 Dec 2023
In December 2023, the government of the Xiong'an New Area (Hebei province) issued state aid measures to support the development of the local life sciences and biotechnology sector.
Source
Number of interventions
8
8 certainly harmful
0 likely harmful
0 liberalising
8 in force
Implementation date
29 Dec 2023
Revocation date:
No revocation date
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
On 29 December 2023, the government of the Xiong'an New Area (Hebei province) issued "Several Measures to Support the Development of Modern Life Sciences and Biotechnology Industries" (Xiong'an Office...
See all
This state act is not part of any Thread yet.